Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Sialosyl‐Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients

Sialosyl‐Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients Colon cancers typically produce mucin. However, it is not known whether tumor mucin plays a biological role in cancer cell behavior. To address this issue, the expression of a mucin‐associated antigen, sialosyl‐Tn, was examined by immunohistochemical study in 128 primary colorectal carcinoma specimens from 137 patients who underwent curative surgical resection. Antigen expression was correlated with disease‐free and overall 5‐year survival. Sialosyl‐Tn antigen expression occurred in 112 (87.5%) tumors, and was independent of age, gender, tumor location, Dukes' stage, depth of invasion, degree of differentiation, and ploidy status. Survival at 5 years for patients with sialosyl‐Tn‐negative versus sialosyl‐Tn‐positive tumors was 100% versus 73% (P < 0.05) and disease‐free survival was 94% versus 73%, respectively (P = 0.12). Although more advanced Dukes' stage, deeper invasion, and aneuploidy were all associated with poorer overall 5‐year survival, antigen‐negative tumors within each of these groups had much better prognoses than antigen‐positive tumors. Multivariate regression analysis revealed that tumor ploidy (P < 0.001) and sialosyl‐Tn expression (P < 0.05) were the two variables of most importance for predicting both disease‐free and overall survival. The authors conclude that sialosyl‐Tn expression is an independent predictor of poor prognosis in colon cancer, and therefore suggest that qualitative mucin alterations may reflect important differences in the biological behavior of these neoplasms. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cancer Wiley

Sialosyl‐Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients

Download PDF
7 pages

Loading next page...
 
/lp/wiley/sialosyl-tn-a-novel-mucin-antigen-associated-with-prognosis-in-8zwNTMCXRA

References (31)

Publisher
Wiley
Copyright
Copyright © 1990 Wiley Subscription Services
ISSN
0008-543X
eISSN
1097-0142
DOI
10.1002/1097-0142(19901101)66:9<1960::AID-CNCR2820660919>3.0.CO;2-X
Publisher site
See Article on Publisher Site

Abstract

Colon cancers typically produce mucin. However, it is not known whether tumor mucin plays a biological role in cancer cell behavior. To address this issue, the expression of a mucin‐associated antigen, sialosyl‐Tn, was examined by immunohistochemical study in 128 primary colorectal carcinoma specimens from 137 patients who underwent curative surgical resection. Antigen expression was correlated with disease‐free and overall 5‐year survival. Sialosyl‐Tn antigen expression occurred in 112 (87.5%) tumors, and was independent of age, gender, tumor location, Dukes' stage, depth of invasion, degree of differentiation, and ploidy status. Survival at 5 years for patients with sialosyl‐Tn‐negative versus sialosyl‐Tn‐positive tumors was 100% versus 73% (P < 0.05) and disease‐free survival was 94% versus 73%, respectively (P = 0.12). Although more advanced Dukes' stage, deeper invasion, and aneuploidy were all associated with poorer overall 5‐year survival, antigen‐negative tumors within each of these groups had much better prognoses than antigen‐positive tumors. Multivariate regression analysis revealed that tumor ploidy (P < 0.001) and sialosyl‐Tn expression (P < 0.05) were the two variables of most importance for predicting both disease‐free and overall survival. The authors conclude that sialosyl‐Tn expression is an independent predictor of poor prognosis in colon cancer, and therefore suggest that qualitative mucin alterations may reflect important differences in the biological behavior of these neoplasms.

Journal

Cancer – Wiley

Published: Jan 1, 1990

There are no references for this article.